Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akshay Uttarkar

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Molecules (Basel, Switzerland)|October 14, 2022
Mycobacterium Time-Series Genome Analysis Identifies AAC2' as a Potential Drug Target with Naloxone Showing Potential Bait Drug SynergismVidya Niranjan, Akshay Uttarkar, Keerthana Murali, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 8, 2023
Design of Novel Imidazopyrazine Derivative against Breast Cancer <i>via</i> Targeted NPY1R AntagonistVidya Niranjan, Vibha R, Sarah Philip, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 25, 2021
Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studiesSinosh Skariyachan, Dharshini Gopal, Dhrithi Deshpande, et al.
Molecular Biotechnology|September 20, 2021
Understanding the Xylooligosaccharides Utilization Mechanism of Lactobacillus brevis and Bifidobacterium adolescentis: Proteins Involved and Their Conformational Stabilities for Effectual BindingIshu Khangwal, Sinosh Skariyachan, Akshay Uttarkar, et al.
Journal of Biomolecular Structure & Dynamics|February 11, 2020
Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant <i>Acinetobacter baumanni</i> and <i>Pseudomonas aerugenosa</i>: computational modeling and MD simulation studiesSinosh Skariyachan, Dharshini Gopal, Sanjana Pratab Kadam, et al.
Structural Chemistry|September 5, 2022
Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2Vidya Niranjan, Anagha Shamsundar Setlur, Chandrashekar Karunakaran, et al.
Structural Chemistry|August 8, 2022
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2Vidya Niranjan, Anagha Shamsundar Setlur, Chandrashekar Karunakaran, et al.
Journal of Biomolecular Structure & Dynamics|January 5, 2022
Coumarin derivative as a potent drug candidate against triple negative breast cancer targeting the frizzled receptor of wingless-related integration site signaling pathwayAkshay Uttarkar, Alice Preethi Kishore, Sudhanva M Srinivas, et al.
Biochemical and Biophysical Research Communications|March 7, 2026
Computational modeling and optimization of scFv-based receptors to support CAR-T design targeting CD19 for enhanced binding robustness and reduced off-target propensityKadalmani Krishnan, Anita Chugh, Ravikrishnan Rajaram, et al.
Computers in Biology and Medicine|October 19, 2020
Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugsSinosh Skariyachan, Dharshini Gopal, Shweta Chakrabarti, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Molecules (Basel, Switzerland)|October 14, 2022
Mycobacterium Time-Series Genome Analysis Identifies AAC2' as a Potential Drug Target with Naloxone Showing Potential Bait Drug SynergismVidya Niranjan, Akshay Uttarkar, Keerthana Murali, et al.
Anti-Cancer Agents in Medicinal Chemistry|May 8, 2023
Design of Novel Imidazopyrazine Derivative against Breast Cancer <i>via</i> Targeted NPY1R AntagonistVidya Niranjan, Vibha R, Sarah Philip, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|November 25, 2021
Carbon fullerene and nanotube are probable binders to multiple targets of SARS-CoV-2: Insights from computational modeling and molecular dynamic simulation studiesSinosh Skariyachan, Dharshini Gopal, Dhrithi Deshpande, et al.
Molecular Biotechnology|September 20, 2021
Understanding the Xylooligosaccharides Utilization Mechanism of Lactobacillus brevis and Bifidobacterium adolescentis: Proteins Involved and Their Conformational Stabilities for Effectual BindingIshu Khangwal, Sinosh Skariyachan, Akshay Uttarkar, et al.
Journal of Biomolecular Structure & Dynamics|February 11, 2020
Carbon fullerene acts as potential lead molecule against prospective molecular targets of biofilm-producing multidrug-resistant <i>Acinetobacter baumanni</i> and <i>Pseudomonas aerugenosa</i>: computational modeling and MD simulation studiesSinosh Skariyachan, Dharshini Gopal, Sanjana Pratab Kadam, et al.
Structural Chemistry|September 5, 2022
Correction to: Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2Vidya Niranjan, Anagha Shamsundar Setlur, Chandrashekar Karunakaran, et al.
Structural Chemistry|August 8, 2022
Scope of repurposed drugs against the potential targets of the latest variants of SARS-CoV-2Vidya Niranjan, Anagha Shamsundar Setlur, Chandrashekar Karunakaran, et al.
Journal of Biomolecular Structure & Dynamics|January 5, 2022
Coumarin derivative as a potent drug candidate against triple negative breast cancer targeting the frizzled receptor of wingless-related integration site signaling pathwayAkshay Uttarkar, Alice Preethi Kishore, Sudhanva M Srinivas, et al.
Biochemical and Biophysical Research Communications|March 7, 2026
Computational modeling and optimization of scFv-based receptors to support CAR-T design targeting CD19 for enhanced binding robustness and reduced off-target propensityKadalmani Krishnan, Anita Chugh, Ravikrishnan Rajaram, et al.
Computers in Biology and Medicine|October 19, 2020
Structural and molecular basis of the interaction mechanism of selected drugs towards multiple targets of SARS-CoV-2 by molecular docking and dynamic simulation studies- deciphering the scope of repurposed drugsSinosh Skariyachan, Dharshini Gopal, Shweta Chakrabarti, et al.
Pageof 4